» Articles » PMID: 22211948

Reversal of Functional Defects in Highly Differentiated Young and Old CD8 T Cells by PDL Blockade

Overview
Journal Immunology
Date 2012 Jan 4
PMID 22211948
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Highly differentiated CD8(+) CD28(-) CD27(-) T cells have short telomeres, defective telomerase activity and reduced capacity for proliferation. In addition, these cells express increased levels of inhibitory receptors and display defective Akt(ser(473)) phosphorylation following activation. It is not known whether signalling via programmed death 1 (PD-1) contributes to any of the attenuated differentiation-related functional changes in CD8(+) T cells. To address this we blocked PD-1 signalling during T-cell receptor (TCR) activation using antibodies against PD-1 ligand 1 (PDL1) and PDL2. This resulted in a significant enhancement of Akt(ser(473)) phosphorylation and TCR-induced proliferative activity of highly differentiated CD8(+) CD28(-) CD27(-) T cells. In contrast, the reduced telomerase activity in these cells was not altered by blockade of PDL1/2. We also demonstrate that PD-1 signalling can inhibit the proliferative response in primary human CD8(+) T cells from both young and older humans. These data collectively highlight that some, but not all, functional changes that arise during progressive T-cell differentiation and during ageing are maintained actively by inhibitory receptor signalling.

Citing Articles

A silver bullet for ageing medicine?: clinical relevance of T-cell checkpoint receptors in normal human ageing.

Rimmer L, Mann D, Sayer A, Amarnath S, Granic A Front Immunol. 2024; 15:1360141.

PMID: 38361938 PMC: 10867193. DOI: 10.3389/fimmu.2024.1360141.


Protein Kinase C at the Crossroad of Mutations, Cancer, Targeted Therapy and Immune Response.

Aquino A, Bianchi N, Terrazzan A, Franzese O Biology (Basel). 2023; 12(8).

PMID: 37626933 PMC: 10451643. DOI: 10.3390/biology12081047.


Counteracting Immunosenescence-Which Therapeutic Strategies Are Promising?.

Hieber C, Grabbe S, Bros M Biomolecules. 2023; 13(7).

PMID: 37509121 PMC: 10377144. DOI: 10.3390/biom13071085.


Sicilian semi- and supercentenarians: identification of age-related T-cell immunophenotype to define longevity trait.

Ligotti M, Accardi G, Aiello A, Aprile S, Calabro A, Caldarella R Clin Exp Immunol. 2023; 214(1):61-78.

PMID: 37395602 PMC: 10711357. DOI: 10.1093/cei/uxad074.


Senescent-like Blood Lymphocytes and Disease Progression in Amyotrophic Lateral Sclerosis.

Yildiz O, Schroth J, Tree T, Turner M, Shaw P, Henson S Neurol Neuroimmunol Neuroinflamm. 2022; 10(1).

PMID: 36323511 PMC: 9673751. DOI: 10.1212/NXI.0000000000200042.


References
1.
van Lier R, Ten Berge I, Gamadia L . Human CD8(+) T-cell differentiation in response to viruses. Nat Rev Immunol. 2003; 3(12):931-9. DOI: 10.1038/nri1254. View

2.
Parish S, Wu J, Effros R . Modulation of T lymphocyte replicative senescence via TNF-{alpha} inhibition: role of caspase-3. J Immunol. 2009; 182(7):4237-43. PMC: 3773494. DOI: 10.4049/jimmunol.0803449. View

3.
Effros R, Dagarag M, Spaulding C, Man J . The role of CD8+ T-cell replicative senescence in human aging. Immunol Rev. 2005; 205:147-57. DOI: 10.1111/j.0105-2896.2005.00259.x. View

4.
Song G, Ouyang G, Bao S . The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med. 2005; 9(1):59-71. PMC: 6741304. DOI: 10.1111/j.1582-4934.2005.tb00337.x. View

5.
Di Mitri D, Azevedo R, Henson S, Libri V, Riddell N, Macaulay R . Reversible senescence in human CD4+CD45RA+CD27- memory T cells. J Immunol. 2011; 187(5):2093-100. DOI: 10.4049/jimmunol.1100978. View